Noah Haber1, Deenan Pillay, Kholoud Porter, Till Bärnighausen. 1. aHarvard T.H. Chan School of Public Health, Boston, Massachusetts, USA bWellcome Trust Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Durban, South Africa cDivision of Infection and Immunity dMRC Clinical Trials Unit, University College London, London, UK.
Abstract
PURPOSE OF REVIEW: Although the concept of the HIV treatment cascade has reached nearly ubiquitous acceptance in international HIV policy and research, methods for estimating it vary drastically. These variations become increasingly important as the focus of the HIV response shifts from emergency response to long-term outcomes and financial and organizational sustainability. We review the history of the cascade and the current literature and develop the first comprehensive typology of cascade scope and methods. RECENT FINDINGS: We define the cascade scope in terms of both breadth (range from first to final event) and depth (given breadth, number of cascade stages that analyzed). We distinguish cascade measurement according to four dimensions: denominator-denominator linkage (data used for cascade construction are linked at the individual level across stages); denominator-numerator linkage (data are linked at the individual level within each stage); single vs. multiple populations from which data sources are drawn; and longitudinal vs. cross-sectional design. SUMMARY: Everything else equal, we would prefer broader and deeper cascades, denominator-denominator linkage, denominator-numerator linkage, single population, and longitudinal data over their respective alternatives. Increased investments in population-based cohorts and data linkage are required to complement clinical cohorts for 'broad' longitudinal cascade analyses.
PURPOSE OF REVIEW: Although the concept of the HIV treatment cascade has reached nearly ubiquitous acceptance in international HIV policy and research, methods for estimating it vary drastically. These variations become increasingly important as the focus of the HIV response shifts from emergency response to long-term outcomes and financial and organizational sustainability. We review the history of the cascade and the current literature and develop the first comprehensive typology of cascade scope and methods. RECENT FINDINGS: We define the cascade scope in terms of both breadth (range from first to final event) and depth (given breadth, number of cascade stages that analyzed). We distinguish cascade measurement according to four dimensions: denominator-denominator linkage (data used for cascade construction are linked at the individual level across stages); denominator-numerator linkage (data are linked at the individual level within each stage); single vs. multiple populations from which data sources are drawn; and longitudinal vs. cross-sectional design. SUMMARY: Everything else equal, we would prefer broader and deeper cascades, denominator-denominator linkage, denominator-numerator linkage, single population, and longitudinal data over their respective alternatives. Increased investments in population-based cohorts and data linkage are required to complement clinical cohorts for 'broad' longitudinal cascade analyses.
Authors: Hana Lee; Joseph W Hogan; Becky L Genberg; Xiaotian K Wu; Beverly S Musick; Ann Mwangi; Paula Braitstein Journal: Stat Med Date: 2017-11-22 Impact factor: 2.373
Authors: Neo Christopher Chung; Carolyn Bolton-Moore; Roma Chilengi; Margaret P Kasaro; Jeffrey S A Stringer; Benjamin H Chi Journal: Trop Med Int Health Date: 2017-01-19 Impact factor: 2.622
Authors: José Tomás Prieto; Dean McEwen; Arthur J Davidson; Alia Al-Tayyib; Lisa Gawenus; Sridhar R Papagari Sangareddy; Joshua Blum; Seth Foldy; Judith C Shlay Journal: Drug Alcohol Depend Date: 2019-07-06 Impact factor: 4.492
Authors: Julia K Rohr; Jennifer Manne-Goehler; Francesc Xavier Gómez-Olivé; Ryan G Wagner; Molly Rosenberg; Pascal Geldsetzer; Chodziwadziwa Kabudula; Kathleen Kahn; Stephen Tollman; Till Bärnighausen; Joshua A Salomon Journal: Sex Transm Infect Date: 2019-06-26 Impact factor: 3.519
Authors: Arthur Robin Williams; Kimberly A Johnson; Cindy Parks Thomas; Sharon Reif; M Eugenia Socías; Brandy F Henry; Charles Neighbors; Adam J Gordon; Constance Horgan; Bohdan Nosyk; Karen Drexler; Noa Krawczyk; Gregg S Gonsalves; Scott E Hadland; Bradley D Stein; Marc Fishman; A Taylor Kelley; Harold A Pincus; Mark Olfson Journal: Subst Abus Date: 2022 Impact factor: 3.984
Authors: Andrew Anglemyer; Noah Haber; Adi Noiman; George Rutherford; Anuradha Ganesan; Jason Blaylock; Jason Okulicz; Ryan C Maves; Tahaniyat Lalani; Christina Schofield; James Mancuso; Brian K Agan Journal: Mil Med Date: 2020-08-14 Impact factor: 1.437